Macrocure Announces New Date for Special General Meeting of Shareholders to Approve Merger With Leap Therapeutics
PETACH TIKVA, Israel, November 25, 2016 -- (Healthcare Sales & Marketing Network) -- Macrocure Ltd. (MCUR), a clinical-stage biotechnology company, today announced that it has delayed the scheduled date for its previously-announced Special General Meeting... Biopharmaceuticals, Oncology, Mergers & Acquisitions Macrocure, Leap Therapeutics, monoclonal antibody, esophageal cancer
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Cancer | Cancer & Oncology | Esophagus Cancer | Marketing | Mergers and Aquisitions | Middle East Health | Pharmaceuticals